Boehringer Ingelheim

Boehringer Ingelheim has tapped RetinAI to support its attempt to develop treatments for geog | Boehringer Ingelheim has tapped RetinAI to support its attempt to develop treatments for geographic atrophy, striking a deal to apply AI tools to its imaging data in a search for novel biomarkers and predictors of disease progression.

Companies will collaborate to boost novel treatments for individuals with geographic atrophy RetinAI Medical – a company focused on clinical and imaging data management using AI…

RetinAI Medical AG, which creates clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, is partnering with Boehringer Ingelheim.  The companies aim to improve patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases.  GA is a progressive,…

RetinAI Medical AG BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, is excited to announce a new partnership with Boehringer Ingelheim. The companies aim to improve patient outcomes in geographic atrophy…

IT and consultant company Cognizant and research-driven biopharma company, Boehringer Ingelheim will be working together to ‘advance the speed and quality of medicinal therapy development’ they say. They will use the Veeva Development Cloud - an operating system for product development that brings together applications for clinical, quality, regulatory, and safety to help organizations drive end-to-end…

Pioneering family-owned Boehringer Ingelheim is making use of cutting-edge data management services provided by Capgemini in its work on breakthrough therapies.  Boehringer Ingelheim specialises in areas of unmet medical need in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing and has focused on advanced technologies to discover new ways of introducing technology to core business…

University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim l

image: Insilico collaborates with Boehringer Ingelheim on artificial intelligence system for target discovery. view more  Credit: Insilico Medicine …